Related content

Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease

By Kobayashi Naoki   Mori Masaaki   Kobayashi Yoshinori   Miyamae Takako   Imagawa Tomoyuki   Okuyama Toshiya   Kurozumi Hiroko   Yokota Shumpei  

Modern Rheumatology, Vol. 14, Iss. 6, 2004-12 ,pp. : 447-452

Springer Publishing Company

Access to resources Recommend Favorite

Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease

By Mori Masaaki   Miyamae Takako   Imagawa Tomoyuki   Katakura Shigeki   Kimura Kazuhiro   Yokota Shumpei  

Modern Rheumatology, Vol. 14, Iss. 5, 2004-11 ,pp. : 361-366

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of intravenous immunoglobulin‐resistant Kawasaki disease with methotrexate

By Ahn S   Kim D. S.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 2, 2005-04 ,pp. : 136-139

Informa Healthcare

Access to resources Recommend Favorite

Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis

By Takahashi Takehiro   Asano Yoshihide   Akamata Kaname   Aozasa Naohiko   Taniguchi Takashi   Noda Shinji   Masui Yuri   Ichimura Yohei   Toyama Tetsuo   Tamaki Zenshiro   Tada Yayoi   Sugaya Makoto   Kadono Takafumi   Sato Shinichi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 884-890

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up

By Tochimoto Akiko  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 296-301

Springer Publishing Company

Access to resources Recommend Favorite